This promising treatment has demonstrated the ability to lower LDL and total cholesterol, with studies showing a reduction of approximately 5.3% in LDL compared to placebo groups
To improve tolerability, treatment begins with a low starting dose that is gradually increased
Moreover, the high costs associated with Wegovy may potentially limit access for some patients, which hampers market growth
Studies suggest that AOD 9604 may offer some relief, which makes it pertinent to joint health
Recently, the Wegovy pill, an oral semaglutide option, was approved by the FDA, providing more choices for those who prefer not to inject
Neurotrophins, cytokines, oxidative stress mediators and mood state in bipolar disorder: systematic review and meta-analyses